Dr. Wong is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
100 Medical Plaza
Suite 550
Los Angeles, CA 90095Phone+1 310-794-4955Fax+1 310-794-4955
Summary
- Dr. Deborah Wong is an oncologist in Los Angeles, CA and is affiliated with multiple hospitals in the area, including Ronald Reagan UCLA Medical Center, UCLA Medical Center-Santa Monica, and Torrance Memorial Medical Center. She received her medical degree from University of California Irvine School of Medicine and has been in practice 11 years. She specializes in head & neck cancer.
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Hematology and Medical Oncology, 2010 - 2013- UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Internal Medicine, 2007 - 2009
University of California, Irvine, School of MedicineClass of 2006
Certifications & Licensure
CA State Medical License 2007 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Phase I Dose-Escalation, Safety, Pharmacokinetic and Pharmacodynamic Study of BVD-523 in Patients With Advanced Malignancies Start of enrollment: 2013 Mar 01
- Efficacy Study of Pembrolizumab in Relapsed, Locally Recurrent Squamous Cell Cancer of the Head and Neck Start of enrollment: 2016 Jul 06
- Pembrolizumab in Treating Participants With Leukoplakia Start of enrollment: 2019 May 03
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- 527 citationsMulti-stage Differentiation Defines Melanoma Subtypes with Differential Vulnerability to Drug-Induced Iron-Dependent Oxidative Stress.Jennifer Tsoi, Lidia Robert, Kim H. T. Paraiso, Carlos Galvan, Katherine M. Sheu
Cancer Cell. 2018-05-14 - 72 citationsSafety profile of avelumab in patients with advanced solid tumors: A pooled analysis of data from the phase 1 JAVELIN solid tumor and phase 2 JAVELIN Merkel 200 clinic...Karen Kelly, Jeffrey R. Infante, Matthew H. Taylor, Manish R. Patel, Deborah J. Wong
Cancer. 2018-05-01 - 108 citationsAvelumab in patients with previously treated metastatic adrenocortical carcinoma: phase 1b results from the JAVELIN solid tumor trialChristophe Le Tourneau, Christopher J. Hoimes, Corrine Zarwan, Deborah J. Wong, Sebastian Bauer
Journal for Immunotherapy of Cancer. 2018-10-22
Authored Content
- The Data Has Not Matured, but the Future of Head and Neck Cancer Treatment Looks ExcitingJune 2019
- The Data Has Not Matured, but the Future of Head and Neck Cancer Treatment Looks ExcitingJune 2019
- New Treatment Options and Support Systems for Head and Neck Cancer Patients on the HorizonFebruary 2018
- New Treatment Options and Support Systems for Head and Neck Cancer Patients on the HorizonFebruary 2018
- New Treatment Options and Support Systems for Head and Neck Cancer Patients on the HorizonFebruary 2018
- Join now to see all
Press Mentions
Testimonial: Tongue Cancer TORS SurgeryNovember 8th, 2024
Alaskan Bush People’s Ami Brown Health Update After Lung Cancer Battle 2019August 22nd, 2019
Combination Approach Shows Promise for Beating Advanced MelanomaAugust 29th, 2018- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
